Related Experiment Video
Updated: Jan 15, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Thiazole peptidomimetics as chemical modulators of KRAS gene expression via G-quadruplex stabilization
Debasmita Biswas1, Ananta Gorai1, Sandip Maiti1
1School of Chemical Sciences, Indian Association for the Cultivation of Science Kolkata 700032 India ocjd@iacs.res.in https://iacs.res.in/athusers/index.php?navid=0&userid=IACS0034#219524.
Abstract:
KRAS is one of the most frequently mutated oncogenes in human cancers and remains a challenging target for therapeutic intervention, often labeled "undruggable." We herein synthesized triazole-containing peptidomimetics TTh1 and TTh2, to explore their selective interactions with DNA quadruplexes. Biophysical studies reveal that TTh2 with a prolinamide motif selectively binds to and stabilizes the KRAS G-quadruplex structure, resulting in marked suppression of the KRAS mRNA and protein levels in HeLa cells. This downregulation correlates with the inhibition of key downstream signaling pathways, including MAPK and Akt/mTOR, which are critical for cancer cell proliferation and survival. These results highlight the potential of G4-binding peptidomimetics as chemical tools for modulating oncogene expression through selective stabilization of promoter G-quadruplex structures.
Insights
Researchers developed novel peptidomimetics targeting KRAS G-quadruplex DNA. TTh2 selectively binds and stabilizes the KRAS G-quadruplex, downregulating oncogene expression and inhibiting cancer cell pathways.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Cancer Research
Background:
- KRAS is a frequently mutated oncogene in human cancers, posing a therapeutic challenge.
- Targeting KRAS has been difficult, with the oncogene often considered
- undruggable
- .
Purpose of the Study:
- To synthesize and evaluate novel triazole-containing peptidomimetics for selective DNA G-quadruplex interactions.
- To investigate the potential of these compounds in modulating oncogene expression and downstream signaling pathways.
Main Methods:
- Synthesis of triazole-containing peptidomimetics (TTh1 and TTh2).
- Biophysical studies to assess DNA G-quadruplex binding and stabilization.
- Analysis of KRAS mRNA and protein levels in HeLa cells.
- Evaluation of downstream signaling pathway inhibition (MAPK, Akt/mTOR).
Main Results:
- TTh2 selectively binds to and stabilizes the KRAS G-quadruplex structure.
- TTh2 treatment resulted in significant suppression of KRAS mRNA and protein levels.
- Downregulation of KRAS correlated with inhibition of MAPK and Akt/mTOR signaling pathways.
- These pathways are critical for cancer cell proliferation and survival.
Conclusions:
- G-quadruplex binding peptidomimetics show potential as therapeutic agents.
- Selective stabilization of promoter G-quadruplex structures can modulate oncogene expression.
- TTh2 represents a promising chemical tool for targeting KRAS-driven cancers.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

